Table 4.
Primary outcomes for patients with PBC
| Placebo (n = 10) | Fluvoxamine (n = 12) | |||||||
| Day 0 | Day 14 | Day 42 | Day 70 | Day 0 | Day 14 | Day 42 | Day 70 | |
| VAS Fatigue | 7.6 | 6.9 | 7.9 | 7.5 | 6.8 | 6.9 | 8.8 | 7.6 |
| FFSS | ||||||||
| Physical Domain | 20 | 18 | 18 | 15 | 16 | 16 | 21 | 21 |
| Cognitive Domain | 9 | 6 | 14 | 8 | 11 | 8 | 10 | 9 |
| Social Domain | 25 | 26 | 28 | 19 | 26 | 20 | 22 | 15 |
| MFI | ||||||||
| General Fatigue | 17 | 15 | 17 | 16 | 16 | 16 | 17 | 16 |
| Physical Fatigue | 14 | 14 | 15 | 16 | 14 | 13 | 14 | 14 |
| Reduction Activity | 13 | 13 | 13 | 11 | 12 | 14 | 14 | 15 |
| Reduction Motivation | 9 | 9 | 12 | 11 | 11 | 13 | 11 | 12 |
| Mental Fatigue | 14 | 12 | 12 | 14 | 13 | 14 | 14 | 12 |
Results are expressed as median scores.